Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03433183
Brief Title: SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

First Submitted : January 29, 2018
First Submitted that Met QC Criteria : February 7, 2018
First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : April 26, 2019
Last Update Posted : April 30, 2019